Cardiovascular (CIRT)

CIRT will examine if taking low-dose methotrextate (LDM) once a week will reduce inflammation and decrease the risk for heart attacks, strokes, and death among men and women who have had a heart attack or have major blockages in more than one coronary artery.

Register Today!

Trial Information

Start DateFebruary 2017
End DateMarch 2019
Trial Duration5 years
Number of VisitsEvery 4 months
Lead CRCAdam Pawluch

For additional information
on this trial contact: